Robert Doody is a seasoned professional in the blockchain and investor relations sectors, currently serving as the Senior Vice President of Investor Relations at Prelude Therapeutics and Dexian. They have a significant history in the field, including leadership roles such as Head of Investor Relations at ViroPharma Incorporated and Vice President at Provention Bio and ConnectWise. Their experience is further complemented by a military background in the United States Navy and a Bachelor of Arts in Communications from Rowan University.
This person is not in any teams
This person is not in any offices